<?xml version="1.0" encoding="UTF-8"?>
<p>A serum sample from a pregnant woman diagnosed according to the WHO classification of diseases (International Classification of Diseases, 10th Revision) with mosquito-borne viral fever, unspecified (A92.9) (
 <ext-link ext-link-type="uri" xlink:href="https://icd.who.int/browse10/2016/en#/A92-A99" xmlns:xlink="http://www.w3.org/1999/xlink">https://icd.who.int/browse10/2016/en#/A92-A99</ext-link>), was collected in the city of Villavicencio (Meta, Colombia) on 17 January 2016 and submitted to the Instituto Nacional de Salud (INS)–Colombia for laboratory diagnosis as part of the national public health surveillance system. ZIKV infection was confirmed by real-time reverse transcription-PCR (RT-PCR) Trioplex assay (Chikungunya virus [CHIKV]-dengue virus [DENV]-ZIKV) (
 <xref rid="B8" ref-type="bibr">8</xref>). Serum was diluted 1:100 in minimal essential medium (MEM), and 200 μl of the dilution was inoculated in Vero cells. Cytopathic effect was observed 6 days after inoculation, and ZIKV was confirmed in cell supernatants by Trioplex assay.
</p>
